Abstract
A polymer-free biolimus A9 coated and eluting stent (PF-BCS) followed by 1-month dual antiplatelet therapy has been shown to be safer and more effective than a bare-metal stent in high bleeding risk patients undergoing PCI in a clinical trial setting. However, little is known about the performance
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have